Botulinum toxin A injection of UES in schizencephaly with dysphagia: Case report.
A 4-year-old schizencephaly patient admitted to authors' institution with dysphagia caused by upper esophageal sphincter (UES) dysfunction. Videofluoroscopic swallowing study (VFSS) was done for the diagnosis and the botulinum toxin type A (BTX-A) was injected to the cricopharyngeal muscle. UES dysfunction improved and oral feeding was possible after the injection. This normal swallowing function remained for over 79 months which was confirmed by follow up VFSS. To the best of our knowledge, this is first case of schizencephaly patient to be treated by BTX-A for UES dysfunction and longest to maintain its effect with single session of injection.
Departments of Physical Medicine & Rehabilitation, Dongguk University College of Medicine, Goyang, South Korea.
Ki Yeun
KY
Nam
Departments of Physical Medicine & Rehabilitation, Dongguk University College of Medicine, Goyang, South Korea.
Changjae
C
Kim
Departments of Physical Medicine & Rehabilitation, Dongguk University College of Medicine, Goyang, South Korea.
Jin Woo
JW
Park
Departments of Physical Medicine & Rehabilitation, Dongguk University College of Medicine, Goyang, South Korea.
Ho Jun
HJ
Lee
Departments of Physical Medicine & Rehabilitation, Dongguk University College of Medicine, Goyang, South Korea. Electronic address: bskwon@dumc.or.kr.
Bum Sun
BS
Kwon
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002675:Child, Preschool; D003680:Deglutition Disorders / Q000188:drug therapy* / Q000209:etiology; D049631:Esophageal Sphincter, Upper; D005260:Female; D006801:Humans; D007267:Injections; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D065707:Schizencephaly / Q000150:complications*; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A
Achalasia; Botulinum toxins; Esophageal sphincter; Schizencephaly; Upper